[Treatment strategy in childhood bronchial asthma].
Although bronchial asthma is the most frequent chronic disease in childhood, not all of the affected children are readily recognised as asthmatics well in time for appropriate treatment. Since most of the children can get rid of the symptoms if all the available treatment methods are made use of systematically, early diagnosis and correct estimation of the disease pattern are essential for good long-term prognosis. New pathogenetic knowledge on the importance of inflammatory processes affecting the bronchial mucosa has definitely shifted the points of emphasis in asthma treatment as is evident from the international consensus recommendations. Focus of drug therapy is on prophylactic antiphlogistic treatment. Only in cases of severe asthma continual bronchodilatory medication is also recommended. The inhalative route is beneficial and feasible for all age groups. Long-term treatment, wherever necessary, also includes continual medical supervision in consultation with a paediatric pneumologist.
Schuster
R
R
Klinik für Kinderheilkunde, Medizinischen Akademie Magdeburg.
Sollich
V
V
Thal
W
W
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D009330:Nebulizers and Vaporizers; D013806:Theophylline / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D013806:Theophylline
Behandlungsstrategie des kindlichen Asthma bronchiale.